THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

INTECH INVESTMENT MANAGEMENT LLC's Holding History (CIK: 0001086318)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 20,444 Value ($000) $383 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 22,676 Value ($000) $331 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 26,690 Value ($000) $294 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 33,287 Value ($000) $297 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 22,935 Value ($000) $216 Avg Close $9.10 Range $7.88 - $10.26

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	20,444	$383	$16.59	$13.50 - $20.33
Q3 2025	22,676	$331	$12.64	$10.82 - $14.87
Q2 2025	26,690	$294	$9.72	$7.90 - $11.82
Q1 2025	33,287	$297	$9.31	$8.35 - $10.90
Q4 2024	22,935	$216	$9.10	$7.88 - $10.26